EISAI
Eisai is a world-leading pharmaceutical company engaged in R&D and outlines as a corporate mission the belief in prioritizing patients and families in order to promote better health - defined by the company as the belief in "Human health care (hhc).
EISAI
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.eisai.it
Total Employee:
1+
Status:
Active
Contact:
+39 0473 224 0967
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Euro
Similar Organizations
MEDIAP
MEDIAP specializes in contractual pharmaceutical manufacturing, storage and pharmaceutical logistic services.
Official Site Inspections
http://www.eisai.it
- Host name: 89.183.207.35.bc.googleusercontent.com
- IP address: 35.207.183.89
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Eisai"
EISAI Italia - EISAI Italia
Eisai Co., Ltd. è una casa farmaceutica leader a livello mondiale nel settore Ricerca e Sviluppo con sede centrale in Giappone e delinea come missione aziendale l’impegno di “dare priorità …See details»
Eisai Group Worldwide | Corporate Information | Eisai Co., Ltd.
Eisai Europe Ltd. EMEA Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, U.K. Tel: 44-208-600-1400 European headquarters / holding company, pharmaceutical salesSee details»
Eisai (company) - Wikipedia
Nihon Eisai Co. Ltd. was established in 1941. In 1944, merger with Sakuragaoka Research Laboratory resulted in creation of Eisai Co. Ltd. The American subsidiary of the company, Eisai Inc., was established in 1995. On November 25, 1996, Eisai received approval from the United States Food and Drug Administration (USFDA) for Aricept (donepezil), a drug discovered in the company's labs and c…See details»
Who We Are - Eisai Europe
Who We Are. We are a global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas and we define our corporate concept as "to give …See details»
Who we are | Eisai Inc.
Eisai came to America in 1987 with one goal in mind: Create innovative new medicines to help patients, their families and caregivers. In 2011, Eisai Canada joined in pursuing this goal. …See details»
Who we are as a medical solutions company | Eisai US
Our Global Mission. Our human health care mission, the desire to contribute to patients, is our corporate philosophy and the core of our business. Established in 1992, the hhc philosophy is …See details»
Eisai - The Org
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical …See details»
EISAI Italia | human health care
Stai per abbandonare il sito EISAI Stai uscendo da eisai.it, sito web di Eisai Italia. Le informazioni contenute nel sito a cui state per accedere potrebbero non essere conformi a quanto previsto …See details»
Eisai Co., Ltd.｜A human health care company
Eisai’s Corporate Pension Fund Announces Adoption of “Asset Owner Principles” October 3, 2024. EISAI NAMED AS ONE OF NEWSWEEK’S WORLD’S MOST TRUSTWORTHY …See details»
Eisai Europe
Eisai in numbers With operations in Asia, Australia, Europe, The Middle East, Latin America, New Zealand and the United States, we employ more than 10,000 people worldwide. 0See details»
Vision and Values - Eisai
Our vision helps us set goals based on the potential of our organization and what we hope it will become. Most importantly, it forms the basis for our business strategies. Our Values. Eisai …See details»
Meet the inspiring leadership team | Eisai US
Mr. Yasuno has full operating responsibility for the management of Eisai’s operating companies and sites in the United States and Canada, including its fully integrated commercial and …See details»
Our History | Eisai Europe
Eisai co-establishes the Global Health Innovative Technology Fund (GHIT Fund), Japan's first public–private partnership to advance development of new health technologies for the …See details»
Vision and Values - Eisai
Our vision helps us set goals based on the potential of our organization and what we hope it will become. Most importantly, it forms the basis for our business strategies. Our Values. Eisai …See details»
Research and Development (R&D) Organization - Eisai Co., Ltd.
Apr 1, 2025 Eisai boasts a drug discovery history of over 40 years in the fields of neurology and oncology. By engaging in over 500 annual hhc activities, we develop a deep sense of empathy …See details»
Eisai at a Glance | About Eisai - Eisai Co., Ltd.
Eisai is promoting initiatives for improving access to medicines in developing and emerging countries. Eisai is committed to supplying tablets free of charge from its Vizag Plant in India to …See details»
Member Organizations and Initiatives That Engage in ... - Eisai Co., …
Eisai became a member of the JCI in December 2020. Pharmaceutical Supply Chain Initiative：PSCI The Pharmaceutical Industry Supply Chain Initiative (PSCI) is a non-profit …See details»
Corporate Governance System and Features - Eisai Co., Ltd.
1) Meeting bodies in operational divisions such as advisory boards. The Company has established the Corporate Strategy Committee and Growth & Operating Committee as …See details»
Eisai Demonstrates Commitment to Oncology Innovation at ASCO …
3 days ago Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025; Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025. For Print; May 21, 2025; …See details»
Our Locations | Eisai US
IT STARTS WITH STRATEGIC VISION . Our U.S. Corporate Headquarters in Nutley, NJ, is the nerve center of a fully integrated pharmaceutical business focused on neurology and …See details»